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a b s t r a c t
A comparative study of the secondary metabolism of two Trichoderma spp. with that of the Thctf1
transcription factor gene null mutant of Trichoderma harzianum 34 was carried out in order to deepen our
knowledge of the biosynthetic pathway and mode of action of 6-pentyl-2H-pyran-2-one (1) and its
derivatives as biocontrol agents. New isolated metabolites have shed light on the detoxification
mechanism of 6-pentyl-pyranone by Trichoderma spp. All new compounds were synthesized and their
stereoisomer characterized. The absolute configuration of 6-[(10R,20S)-dihydroxypentyl]-2H-pyran-2-one
and 6-((10S,20R)-20-propyloxiran-1-yl)-2H-pyran-2-one was determined by NMR analysis of the corre-
sponding Mosher’s esters.
 2009 Elsevier Ltd. All rights reserved.
1. Introduction
Biological control provides an alternative to the use of synthetic
pesticides with the advantages of greater public acceptance and
reduced environmental impact. Many of the soils that naturally
suppress plant diseases are rich in organic matter that supports the
growth of beneficial microorganisms. Use of these microorganisms
as biological control agents seeks to restore the beneficial balance
of natural ecosystems, which is often lost in crop situations.1
Trichoderma species are free-living fungi, which are highly
interactive in root, soil, and foliar environments. Considered to be
eager colonizers and particularly invasive fungi, their mechanisms
of biocontrol include mycoparasitism, competition for nutrients
and antibiosis, as well as plant growth promotion2 and plant de-
fense signaling activation.3
This dominance is achieved by biosynthesizing a wide array of
secondary metabolites, transforming a great variety of natural and
xenobiotic compounds4 and producing varied fungal cell wall
degrading enzymes (CWDEs) such as chitinases, proteases, or
glucanases.5
Trichoderma species and their metabolites have been the focus
of considerable attention over the last several years as potential
biological control agents of a variety of plant pathogenic fungi.6,7
It is clear that the ability of Trichoderma to inhibit the growth of
other fungi is probably due to the combined action of CWDEs
together with the capacity of Trichoderma to produce different
secondary metabolites.8 The secondary metabolites with antibiotic
activity produced by Trichoderma have been classified into different
groups based on their biosynthetic origin or their chemical
structure.9,10
Some metabolites have been associated with the antagonistic
ability of Trichoderma, but none of them has been identified as the
sole agent responsible for it. One of the first volatile antifungal
compounds isolated from Trichoderma species was 6-pentyl-2H-
pyran-2-one (6PP) (1) from Trichoderma viride,11 which has sub-
sequently been isolated from several Trichoderma species.12,13
6PP is responsible for the ‘coconut aroma’ associated with cer-
tain strains of Trichoderma,14 and it is also well known that it can
inhibit the growth of a range of phytopathogens, such as Botrytis
cinerea, Rhizoctonia solani, Armillaria mellea,15 Penicillium expan-
sium, and Fusarium graminearum,16 and also affects the biomass
growth of Trichoderma species.17 Several of these fungi are able to
metabolize 1 into products of reduced toxicity to themselves, as
a part of the fungal detoxification mechanism.16,18,19
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Following up on our project oriented toward the study of the
secondary metabolism of Trichoderma spp. and the growth in-
hibition mechanism exerted by these species on phytopathogen
fungi, Rubio and co-workers20 have isolated, characterized, and
functionally analyzed, by gene disruption, the first Thctf1 tran-
scription factor gene related to 6-pentyl-2H-pyran-2-one pro-
duction in Trichoderma harzianum. In addition, a comparative study
on the secondary metabolism of two wild Trichoderma spp. with
that of the Thctf1 gene null mutant strain was carried out. This
paper deals with the characterization, synthesis, and absolute
configuration of the new metabolites isolated from both wild
strains. Some considerations regarding the detoxification mecha-
nism of 6PP by the fungus B. cinerea are likewise reported.
2. Results and discussion
In order to enhance our knowledge in the biosynthetic pathway
and in the mode of action of 6-pentyl-2H-pyran-2-one (1) and its
derivatives as biocontrol agents, we have conducted a comparative
study on the secondary metabolism and the production of pen-
tylpyrone derivatives by the null transformant and two wild-type
strains of Trichoderma: T. harzianum CECT 2413, the parental strain
of the Thctf1 null mutant, and the wild strain T. viride UCA 06.
Study of the extract obtained from the broth of Thctf1 null
mutant (see Experimental section) did not produce 6PP or any of its
derivatives and exerted a lower antimicrobial effect than the wild-
type strain. These results linked the transcription factor Thctf1 gene
of T. harzianum to the production of secondary metabolites and
antifungal activity against plant pathogenic fungi.
Fermentation and isolation procedures of the products obtained
from the broth of both wild-type of Trichoderma strains were
carried out as described in Experimental section. Under these
conditions, in addition to 1, compounds 3, 5 and 2–4, 7, retaining
the pyrone ring (Scheme 1), were isolated from T. harzianum T34
and T. viride UCA 06, respectively.
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Scheme 1. Metabolites isolated from the Trichoderma spp.
Spectroscopic data for structures 2, 3, and 4 coincided with
those described in the literature for compounds 6-(5-hydroxy-
pentyl)-2H-pyran-2-one (2),16,18 6-(4-hydroxypentyl)-2H-pyran-2-
one (3),18 and 6-(4-oxopentyl)-2H-pyran-2-one (viridepyronone)
(4).21 Products 2 and 3 have previously been described as products
resulting from the biotransformation of 6-pentyl-2H-pyran-2-one
(1) by several fungal isolates,16,18 but not as secondary metabolites
from Trichoderma species. Compound 5was obtained as a colorless
oil with the molecular formula C10H14O4, obtained from its HRMS
and corroborated by 13C NMR data. The 1H NMR and 13C NMR
spectra showed that it retained the pyrone ring and presented
signals characteristic of two protons geminal to hydroxyl groups at
d 4.24 (br s, 1H, H-10) and 3.98 (m, 1H, H-20).
The proposed structure 5 was confirmed by its diacetyl de-
rivative (6), which, in addition to the signals corresponding to the
methyl of acetate groups, 2.03 (s) and 2.14 (s), showed two
characteristic signals of protons geminal to the acetoxy groups
deshielded at d 5.56 (d, 1H, H-10) and 5.28 (ddd, 1H, H-20), re-
spectively. Furthermore, structure 5 was supported by homo- and
heteronuclear-2D-correlation experiments. The stereochemistry at
both hydroxyl groups was confirmed by chemical correlation as
indicated below.
From the fermentations of T. viride UCA 06 carried out with
the secondary metabolites elicitor (see Experimental section), in
addition to 2–4, compounds 1 and 7–9 were also isolated.
Spectroscopic data for product 8 coincided with those previously
reported for a characteristic metabolite of this species, trichovir-
idine22 (8). Tyrosol (9)23 is a known compound, which is reported
here for the first time as a secondary metabolite isolated from
T. viride.
Epoxy-compound 7 was isolated as a colorless oil, with an Mþ
peak at m/z 180 and gave rise to a 13C NMR spectrum consistent
with the molecular formula C10H1203. The
1H NMR spectrum was
close to that of 6-pentyl-2H-pyran-2-one (1), but the appearance of
two signals at 3.17 and 3.36 ppm in the 1H NMR spectrum and at
61.1 and 54.3 ppm in the 13C NMR spectrum (H-20 and H-10, re-
spectively) showed that 7 was a 6-pentyl-2H-pyran-2-one epoxy
derivative. Compound 6-(20-propyloxiran-1-yl)-2H-pyran-2-one
(7), is reported here for the first time.
In order to assign the absolute configuration of new compounds
5 and 7, we proceeded to the synthesis and characterization of the
stereoisomers of both compounds, as indicated in Scheme 2.
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Scheme 2. (a) NBS, (PhCO)2O2; (b) LiBr/Li2CO3; (c) m-CPBA; (d) OsO4/NMO; (e) HClO4
(2 N); (f) DMAP, DCC and (R)-MPA or (S)-MPA.
The synthesis started with commercially available 6PP (1),
which was quantitatively converted into 6-(10-bromopentyl)-2H-
pyran-2-one (10) upon treatment with N-bromosuccinimide (NBS)
and a catalytic amount of benzoyl peroxide in CCl4.
24
Compound 10was obtained as a colorless oil with the molecular
formula C10H13BrO2, determined from its HRMS and corroborated
by 13C NMR data. The 1H NMR and 13C NMR spectra showed that it
retained the pyrone ring and presented a characteristic signal at
d 4.50 (t, 1H, J¼7.7 Hz, H-10) and 48.0 (d, C-10), respectively,
according to structure 10.
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The formation of side-chain olefin was carried out in basic
medium (LiBr/LiCO3)
25 affording 1126 at a yield of 75%. The former
represented the starting material for the synthesis pathway leading
to the threo- and erythro-diol derivatives 12–15, and both epoxy
enantiomers 7a and 7b.
The racemic mixture of threo-10,20-diol 12/13 was obtained at
a yield of 80% by dihydroxylation using common osmium tetroxide/
trimethylamine N-oxide dehydrate.
Moreover, the racemic mixture of erythro-10,20diols 14/15 was
afforded by two subsequent reactions, epoxidation of the olefin 11
with m-chloroperbenzoic acid (m-CPBA) to give epoxide 7 (81%)
and ring opening of this by treatment with perchloric acid (6%) in
dimethoxyethane (DME). The erythro-diol racemic mixture was
obtained at a yield of 70%, along with product 16 (20%) and 5% of
recovered starting material.
Reaction of the threo-diol racemic mixture with the (R)-a-
methoxy phenyl acetic acid ((R)-MPA) and (S)-a-methoxy phenyl
acetic acid ((S)-MPA), separately, and DCC27 gave the corresponding
Mosher diastereoisomer esters, which were easily separated by
HPLC to yield esters 12a, 12b, 13a, and 13b.
Similarly, the corresponding Mosher esters were obtained from
the racemic erythro-diols with (R)-MPA and (S)-MPA, respectively,
as outlined in Scheme 2 to give esters 14a, 14b, 15a, and 15b.
The modified Mosher’s method has been proven useful for
acyclic 1,2-glycols possessing simple alkyl groups28 and more
recently Riguera’s group29 predicted four general patterns for 1,2-
diols. In accordance with this method, we undertook the analysis of
1H NMR spectra of all di-MPA esters already prepared to determine
the absolute configuration of the two vicinal carbinol carbons
C-10/C-20. As pointed out in Table 1, the positive value of ddRS
(ddRS[Ha(10)]¼dR[Ha(10)]dS[Ha(10)]) for H-10 and H-20 indicated
10R,20S configuration in 12a and 12b, whilst the negative value of
DdRS showed (10S,20R) configuration in 13a and 13b. Similarly, the
(10S,20S) configuration in both 14a and 14b and the (10R,20R) con-
figuration in 15a and 15bwere also established by the Mosher ester
method.
Hydrolysis of the corresponding di-MPA ester diastereoisomers,
separately, under alkaline conditions (K2CO3, MeOH),
30 produced
single enantiomers 12–15, which were purified by SiO2 flash
chromatography and isolated in their pure forms. Optical rotations
of synthetic enantiomers 12–15were found to be those indicated in
Experimental section. The absolute configuration of the naturally
occurring diol derivative 5 ([a]D
25 þ122.5 (c 0.11, MeOH)) was
established as (10R,20S) by comparison with the optical rotations
showed by the synthetic enantiomer (12), [a]D
25 þ120.6 (c 0.15,
MeOH) confirming its structure as 6-[(10R,20S)-10,20-dihydroxy-
pentyl]-2H-pyran-2-one.
On the other hand, epoxy enantiomers 7a and 7b were sepa-
rated by HPLC (hexane/isopropanol 95:5), using a chiral column,
from the racemic mixture obtained from the treatment of 11 with
m-CPBA (see Experimental section). The optical activity was mea-
sured for both enantiomers and compared with that displayed by
the natural epoxide obtained from T. viride. The enantiomer 7a,
which presented the same aD as the natural epoxide, was treated
with perchloric acid (6%) in dimethoxyethane (DME) and the
physical and spectroscopic constants of the former dihydroxy de-
rivative were measured and compared with those exhibited by
diols 12–15. The erytro-dihydroxy derivative 15 was obtained
indicating that the natural epoxide corresponded to 6-((10S,20R)-20-
propyloxiran-1-yl)-2H-pyran-2-one (7a).
As mentioned above, compounds 2–4 and several 6PP hydroxy-
lated derivatives in position C-10-C-50 were isolated as a result of
microbial transformation of 1 by selected fungal isolates,16,18,19 in-
cluding B. cinerea. These authors concluded that different phyto-
pathogenic fungi have the ability to transform a potentially toxic
secondary metabolite, from a competitive fungus, into products of
reduced toxicity to itself, indicating the existence of a detoxification
mechanism in a number of fungal genera.18 With this in mind, we
have undertaken the study of a possible self-detoxification mech-
anism of 1 by Trichoderma spp.
Hence, compounds 1–7 were evaluated for their in vitro anti-
fungal activity against the phytopathogen fungus B. cinerea, fol-
lowing the poisoned food bioassay.31 The commercial fungicide
dichlofluanid was used as a standard for comparison in this test.
The results showed (see Experimental section) that the oxidized
metabolites 2–5 were inactive or displayed very low fungicide ac-
tivity at 100 ppm and, in general, they displayed lower fungicide
activity than compound 1. These results seem to indicate that
Trichoderma spp. possesses a mechanism whereby to detoxify
compound 1 to the less toxic compounds 2–5, by hydroxylation of
positions C01-C0-5 of compound 1.
3. Conclusions
In conclusion, preparation of enantiomeric pure compounds 7a
and 7b, and 12–15 allowed us to determine the absolute config-
uration of the new metabolites isolated from Trichoderma spp. The
isolated metabolites, together with the results obtained from
fungicide bioassays have revealed an interesting detoxification
mechanism, shedding light on the secondary metabolism of
Trichoderma spp. The existence of this microbial detoxification
pathway for the fungistatic agent 6PP (1) suggests that it might
not persist in the environment for a prolonged period and it would
be of interest as an ecological fungicide–fungistatic against phy-
topathogen fungi or display signaling functions in soil and
rhizosphere.32
4. Experimental section
4.1. General experimental procedures
Optical rotations were determined with a Perkin–Elmer 241
polarimeter. IR spectra were recorded on a Mattson Genesis spec-
trophotometer, series FTIR. 1H and 13C NMR measurements were
obtained on Varian Unity 400 NMR spectrometers with SiMe4 as
the internal reference. Mass spectra were recorded on a GC–MS
Thermoquest spectrometer (model: Voyager), and a VGAutospec-Q
spectrometer. High-performance liquid chromatography (HPLC)
was performed with a Hitachi/Merck L-6270 apparatus equipped
with a UV–vis detector (L4250) and a differential refractometer
detector (RI-71). Thin layer chromatography (TLC) was performed
onMerck Kiesegel 60F254, 0.2 mm thick. Silica gel (Merck) was used
for column chromatography. Purification by means of HPLC was
accomplished with a silica gel column (Hibar 60, 7 m, 1 cm wide,
25 cm long). Racemic mixtures were separated by means of HPLC
analysis on chiral column (Chiracel OD, Daicel, Japan). Chemicals
were products of Fluka or Aldrich. All solvents used were freshly
distilled.
4.2. Microorganism cultures
The cultures of T. harzianum CECT 2413 and T. viride UCA 06
employed in this study were obtained from the ‘Coleccio´n Espan˜ola
Table 1
DdRS[Ha(X0)]¼dR[Ha(X0)]dS[Ha(X0)] for compounds 12–15
Compounds DdRS[Ha(10)] DdRS[Ha(20)]
12 þ0.08 þ0.05
13 0.095 0.061
14 þ0.11 0.214
15 0.11 0.212
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de Cultivos Tipo’ (CECT), Facultad de Biologı´a, Universidad de
Valencia, Spain and from the mycological collection of the Micro-
biological Department, Universidad de Ca´diz, respectively, where
cultures of these strains are on deposit.
4.3. General culture conditions
Fungi were grown at 25 C on a PDB medium (150 mL per Roux
bottle) in 20 Roux bottles. Cultivation was carried out for 13 days
under static conditions and artificial light (day light type). The
mycelium was subsequently filtered and then washed with brine
and ethyl acetate. The broth was extracted three times with ethyl
acetate and the extract dried over anhydrous sodium sulfate. The
solvent was then evaporated and the residue chromatographed
first on a silica gel column and then compounds from different
fractions were purified by HPLC.
4.4. Culture condition with elicitor
T. viridewas grown at 25 C on a PDB medium (150 mL per Roux
bottle). After two days’ growth, nicotinic acid dissolved in ethanol
(150 ppm per flask) was then distributed over 61 Roux bottles as
a secondary metabolite elicitor. Fermentation continued for five
days, after which the myceliumwas filtered and then washed with
brine and ethyl acetate. The broth was extracted three times with
ethyl acetate and the extract was dried over anhydrous sodium
sulfate. The solvent was then evaporated and the residue treated as
indicated in the general procedure.
4.5. Microorganism and antifungal assays
The B. cinerea 2100 employed in thisworkwas obtained from the
CECT, where a culture of this strain is on deposit. Bioassays were
performed by measuring the inhibition of radial growth on an agar
medium in a Petri dish. The test compoundwas dissolved in acetone
yielding final compound concentrations of 100 mg L1. Solutions of
the test compound were added to a glucose–malt–peptone–agar
medium (61 g of glucose–malt–peptone–agar per liter, pH 6.5–7.0).
The final acetone concentration was identical in both control and
treated cultures. The medium was poured into sterile plastic Petri
dishes measuring 9 cm in diameter and a mycelia disc of B. cinerea
cut from an actively growing culture measuring 5 mm in diameter
was placed in the center of the agar plate. Growth inhibition was
calculated as the percentage of inhibition of radial growth relative
to the control (I%) and was measured for seven days. The assays
were carried out in triplicate and the results are shown as mean
values of three replicates of colony diameters; (SD). The com-
mercial fungicide dichlofluanid was used throughout as a standard
for comparison.
4.6. Products isolated from Thctf1 null mutant
The broth obtained from the fermentation of the null mutant
was filteredwith Nylon 200 mmfilter and treated as indicated in the
general culture procedure to yield a dense oil, which was chro-
matographed and the fractions obtained were collected and puri-
fied by high-pressure liquid chromatography (HPLC). Study of the
fraction obtained by spectroscopic methods, specifically 1H NMR
and 13C NMR, revealed the presence of fatty acids, triglycerides, and
phthalate derivatives.
4.7. Products isolated from T. viride UCA06
Following the general culture procedure, after chromatography
the extract yielded compounds (1) (500 mg), trichoviridin (8)22
(97 mg), and tyrosol (9)23 (13.7 mg).
From fermentation with nicotinic acid as the elicitor chroma-
tography of the extract obtained from the broth yielded 6-pentyl-
2H-pyran-2-one (1) (1.3 g), 6-(5- hydroxypentyl)-a-pyrone (2)
(7.6 mg), 6-(4-hydroxypentyl)-2H-pyran-2-one (3) (1.6 mg),16,18
viridepyronone (4)21 (16 mg), and 6-((10S,20R)-20-propyloxiran-1-
yl)-2H-pyran-2-one (7a) (6 mg).
4.8. Products isolated from T. harzianum
Chromatography of the fermented extract gave 6-pentyl-2H-
pyran-2-one (1) (223 mg), 6-(4-hydroxypentyl)-2H-pyran-2-one
(3) (2.2 mg), and 6-[(10R,20S)-dihydroxypentyl]-2H-pyran-2-one (5)
(4.3 mg).
4.8.1. 6-[(10R,20S)-Dihydroxypentyl]-2H-pyran-2-one (5)
[a]D
25 þ122.5 (c 0.11, MeOH). IR (film): nmax¼3388, 1714, 1632,
1556, 1088, 812 cm1. 1H NMR (400 MHz, CDCl3): d¼7.34 (dd, J¼6.4,
9.2 Hz, 1H, 4-H), 6.36 (d, J¼6.4 Hz, 1H, 5-H), 6.18 (d, J¼9.2 Hz, 1H,
3-H), 4.24 (br s,1H,10-H), 3.98 (m,1H, 20-H), 1.48 (m, 4H, 30-H, 40-H),
0.93 (t, J¼7.0 Hz, 3H, 50-H) ppm. 13C NMR (100 MHz, CDCl3):
d¼165.1 (s, C-2), 162.2 (s, C-6), 143.7 (d, C-4), 114.2 (d, C-3), 102.9 (d,
C-5), 73.2 (d, C-10), 71.8 (d, C-20), 35.4 (t, C-30), 18.9 (t, C-40), 13.9 (q,
C-50) ppm. MS: m/z¼180 (2) [MH2O]þ, 130 (11), 97 (8), 55 (5).
HRMS calcd. for C10H14O4: 198.0888; found: 199.1018 [Mþ1]þ.
4.8.2. 6-[(10R,20S)-Diacetoxypentyl]-2H-pyran-2-one (6)
Compound (5) (3 mg) and acetic anhydride (1 mL) were dis-
solved in dry pyridine (330mL) and the mixture was stirred 26 h at
room temperature. The excess of acetic anhydride was then elim-
inated with cyclohexane and acetone and evaporated in a rotary.
The residuewas purified by column chromatography using hexane-
EtOAc (10%) as an eluent to give 6 in a 90% yield as an oil; 1H NMR
(400 MHz, CDCl3): 7.29 (1H, dd, J¼6.4, 9.5 Hz, H-4), 6.24 (1H, d,
J¼9.5 Hz, H-5), 6.20 (1H, d, J¼6.4 Hz, H-3), 5.56 (1H, d, J¼4.6 Hz, H-
10), 5.28 (1H, ddd, J¼4.6, 8.5, 4.6 Hz, H-20), 2.14 (3H, s, CH3COO-),
2.03 (3H, s, CH3COO–), 1.30 (4H, m, H-20 y H-30), d¼0.90 (3H, t,
J ¼7.4 Hz, H-50); RMN 13C (100 MHz, CDCl3) d¼170.1 (s, CH3COO–),
169.4 (s, CH3COO–), 160.9 (s, C-2), 159.4 (s, C-6), 142.7 (d, C-4), 115.6
(d, C-3), 103.8 (d, C-5), 72.2 (d, C*-10), 72.1 (d, C*-20), 31.7 (t, C-30),
20.8 (c, CH3COO-), 20.7 (c, CH3COO-), 18.5 (t, C-40), 13.7 (c, C-50),
*¼interchangeable.
4.8.3. 6-[(10S,20R)-20-Propyloxiran-1-yl]-2H-pyran-2-one (7a)
[a]D
25 90.0 (c 0.45, CHCl3). 1H NMR (400 MHz, CDCl3): d¼7.27
(dd, J¼6.7, 9.5 Hz, 1H, 4-H), 6.22 (d, J¼9.5 Hz, 1H, 3-H), 6.18 (d,
J¼6.7 Hz, 1H, 5-H), 3.36 (d, J¼2.0 Hz, 1H, 10-H), 3.17 (ddd, J¼2.0, 5.1,
6.1 Hz, 1H, 20-H), 1.62 (m, J¼5.1 Hz, 2H, 30-H), 1.51 (m, J¼7.4 Hz, 2H,
40-H), 0.97 (t, J¼7.4 Hz, 3H, 50-H) ppm. 13C NMR (100 MHz, CDCl3):
d¼161.3 (s, C-6), 161.2 (s, C-2), 143.1 (d, C-4), 115.2 (d, C-3), 102.3 (d,
C-5), 61.1 (d, C-20), 54.3 (d, C-10), 33.7 (t, C-30), 19.0 (t, C-40), 13.8 (q,
C-50) ppm. MS: m/z¼180 (2) [M]þ, 126 (100), 97 (7), 95 (10). HRMS
calcd. for C10H12O3: 180.0783; found: 181.0866 [Mþ1]þ.
4.9. Hemisynthesis of enantiomeric pure compounds
6-[(10S,20R)-20-propyloxiran-1-yl]-2H-pyran-2-one (7a)
and 6-[(10R,20S)-20-propyloxiran-1-yl]-2H-pyran-2-one (7b)
4.9.1. () 6-(20-Propyloxiran-1-yl)-2H-pyran-2-one (7)
m-CPBA (77%, 2.94 g, 13.15 mmol) was added to a solution of the
olefin 11 (1.8 g, 10.96 mmol) in CH2Cl2 (150 mL) at 0 C and the
mixture warmed up to room temperature (24 C) within 14 h. A
Compound 1 2 3 4 5 Control
%I/4d. 1000 151 102 152 251 1000
%I/7d. 642 61 d 71 152 1000
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solution of Na2SO3 (40 mL) was added and the aqueous phase was
extracted with CH2Cl2 (420 mL), the combined organic phases
were washed with NaHCO3 (40 mL) and brine (40 mL), dried with
Na2SO4, and concentrated in vacuo. The residue was purified by
flash chromatography (hexane/ethyl acetate, 85:15) to obtain 1.73 g
(81%) of the desired racemic epoxide 7 as a colorless oil whose
spectral data were identical to those isolated from T. viride. The
racemic mixture of epoxide 7 was separated by means of HPLC
analyses on a chiral column (Chiralcel OD, Daicel, Japan): 254 nm,
0.5 mL/min, hexane/isopropanol (9.5:0.5) yielding enantiomeri-
cally pure epoxides 7a [a]D
2591.6 (c 0.55, CHCl3) and 7b [a]D25þ93.8
(c 0.56, CHCl3).
Epoxide 7a (3 mg) in dimethoxyethane (DME) (1 mL) was
treated with perchloric acid (0.25 mL, 6% in water) at 0 C. The re-
action mixture was stirred for 6 h at room temperature (24 C) and
then poured into water (2 mL) and extracted with 2 mL of ether.
The ether extracts were washed with saturated solution of bi-
carbonate sodium and water, dried over MgSO4, and concentrated.
The resulting oil was chromatographed yielding 6-[(10R,20R)-dihy-
droxypentyl]-2H-pyran-2-one (15) (2 mg) [a]D
25 þ81.75 (c 0.15,
MeOH).
4.10. Hemisynthesis of enantiomeric pure compounds 12–15
4.10.1. 6-(10-Bromopentyl)-2H-pyran-2-one (10)
Compound 1 (1 g, 6.02 mmol), NBS (2.14 g, 7.2 mmol), and
benzoyl peroxide (145 mg, 0.6 mmol) were dissolved in CCl4
(18 mL) and then refluxed at 90 C for 12 h. The reaction mixture
was cooled to room temperature, diluted with water, extracted
with Et2O, and the combined organic phases were washed with
brine, dried (Na2SO4), and evaporated to dryness under reduced
pressure. Purification of crude product by flash column chroma-
tography (silica gel, 15% EtOAc in hexane, gradient elution) pro-
vided the desired product 10 (1.43 g, 97%) as an oil. 1H NMR
(400 MHz, CDCl3): d¼7.22 (dd, J¼6.6, 9.3 Hz, 1H, 4-H), 6.17 (d,
J¼9.3 Hz, 1H, 3-H), 6.15 (d, J¼6.6 Hz, 1H, 5-H), 4.50 (t, J¼7.7 Hz, 1H,
10-H), 2.07 (m, 2H, 20-H), 1.32 (m, 1H, 30a-H), 1.26 (m, 3H, 30b-H,
40-H), 0.83 (t, J¼6.9 Hz, 3H, 50-H) ppm. 13C NMR (100 MHz, CDCl3):
d¼162.3 (s, C-6), 161.1 (s, C-2), 142.9 (d, C-4), 115.8 (d, C-3), 103.1 (d,
C-5), 48.0 (d, C-10), 35.4 (t, C-20), 29.7 (t, C-30), 21.8 (t, C-40), 13.7 (q,
C-50) ppm. MS: m/z¼165 (100), 244 (30), 246 (20). HRMS calcd. for
C10H13BrO2: 244.1125; found: 244.0116.
4.10.2. 6-(Pent-10-enyl)-2H-pyran-2-one (11)25
LiBr (2.1 g, 24.47 mmol) and Li2CO3 (1.8 g, 24.47 mmol) were
added to a solution of 10 (1 g, 4.08 mmol) in DMF (35 mL) and the
mixture was heated in an oil bath at 110 C under argon atmo-
sphere for 1 h. After cooling, H2O was added and the reaction
mixture was extracted three times with Et2O. The organic layer was
dried (MgSO4) and evaporated under vacuum. The residue was
purified by flash column chromatography (silica gel, 15% EtOAc in
hexane, gradient elution) to afford the desired product 11 (0.5 g,
75%), whose spectroscopic data coincided with those reported
previously.
4.10.3. threo-Diols 6-(10,20-dihydroxypentyl)-2H-pyran-2-one
racemic mixture (12þ13)
The dihydroxylation of the double bond was conducted under
standard catalytic conditions. Trimethylamine N-oxide dihydrate
(1.35 g, 12 mmol) and osmium tetraoxide (77 mg, 0.3 mmol) were
added to a solution of olefin 11 (1 g, 6 mmol) in t-BuOH/H2O (2/1,
25 mL). After 2 h of refluxing, the mixturewas cooled to room 25 C
and partitioned between brine (30 mL) and ethyl acetate (40 mL).
The organic layer was separated and the aqueous one extracted
with ethyl acetate (420 mL), and the combined organic solutions
were dried and concentrated. Purification of the crude product by
column chromatography (hexane/ethyl acetate, 1:1) afforded the
title racemic threo-diols (12þ13) as an oil (0.96 g, 80%) whose
spectral data were identical to those of the natural compound 5.
4.10.4. erythro-Diols 6-(10,20-dihydroxypentyl)-2H-pyran-2-one
racemic mixture (14þ15)
Perchloric acid (0.5 mL, 6% in water) at 0 C was added to a so-
lution of the epoxide 7 (295 mg, 1.64 mmol) in dimethoxyethane
(DME) (5 mL). The reaction mixture was stirred for 8 h at room
temperature (24 C) and then poured into water (20 mL) and
extracted with 25 mL (3) of ether. The combined ether extracts
were washed with a saturated solution of bicarbonate sodium and
water, dried over MgSO4, and concentrated. The resulting oil was
chromatographed on silica gel with hexane and ethyl acetate to
afford the racemic mixture of 14þ15 (227 mg, 70%) and the rear-
ranged compound 16 (59 mg, 20%).
4.10.5. 6-(10,20-Dihydroxypentyl)-2H-pyran-2-one racemic mixture
(14þ15)
IR (film): nmax¼3383, 1710, 1632, 1560, 1091, 812 cm1. 1H NMR
(400 MHz, CDCl3): d¼7.32 (dd, J¼6.7, 9.5 Hz, 1H, 4-H), 6.33 (d,
J¼6.7 Hz, 1H, 5-H), 6.11 (d, J¼9.5 Hz, 1H, 3-H), 4.38 (d, J¼4.1 Hz, 1H,
10-H), 3.87 (m, 1H, 20-H), 1.35 (m, 4H, 30-H, 40-H), 0.80 (t, J¼7.2 Hz,
3H, 50-H) ppm. 13C NMR (100 MHz, CDCl3): d¼164.7 (s, C-2), 162.7
(s, C-6), 144.2 (d, C-4), 113.8 (d, C-3), 103.3 (d, C-5), 73.6 (d, C-10),
72.6 (d, C-20), 33.1 (t, C-30), 18.7 (t, C-40), 13.8 (q, C-50) ppm. MS:
m/z¼162 (2) [M2H2O]þ, 130 (11), 126 (100), 97 (16), 55 (12).
4.10.6. 6-(2-Oxopentyl)-2H-pyran-2-one (16)
IR (film): nmax¼1724, 1636, 1377, 1098, 807 cm1. 1H NMR
(400 MHz, CDCl3): d¼7.26 (dd, J¼6.7, 9.5 Hz, 1H, 4-H), 6.16 (d,
J¼9.5 Hz, 1H, 3-H), 6.08 (d, J¼6.7 Hz, 1H, 5-H), 3.52 (s, 2H, 10-H),
2.46 (t, J¼7.4 Hz, 2H, 30-H), 1.55 (q, J¼7.4 Hz, 2H, 40-H), 0.86 (t,
J¼7.4 Hz, 3H, 50-H) ppm. 13C NMR (100 MHz, CDCl3): d¼203.8 (s,
C-20), 162.3 (s, C-6), 158.1 (s, C-2), 143.7 (d, C-4), 113.9 (d, C-3), 104.5
(d, C-5), 48.2 (t, C-10), 44.1 (t, C-30), 16.7 (t, C-40), 14.4 (q, C-50) ppm.
MS: m/z¼180 (12), 137 (5), 110 (100), 95 (14), 71 (45). HRMS calcd.
for C10H12O3: 180.0783; found: 180.1775 [M]
þ.
4.11. Mosher’s diesters: general procedure
DMAP (6.2 mg, 0.05 mmol), DCC (147.9 mg, 0.55 mmol), and (R)-
MPA or (S)-MPA (92.3 g, 0.55 mmol) were added to a stirred solu-
tion of threo- and erythro-diol racemic mixture (50 mg, 0.25 mmol)
in dichloromethane (1 mL) at room temperature. The resulting
mixture was stirred for 48 h. Precipitates were removed by filtra-
tion over Celite and washed with pentane (56 mL). The filtrate
was subsequently washed with a 1.0 M aqueous HCl solution
(23 mL), a saturated aqueous NaHCO3 solution (23 mL), and
a saturated aqueous NaCl solution (3 mL). The organic layer was
dried (MgSO4) and concentrated under reduced pressure. The res-
idue was purified by flash chromatography (silica gel, hexane/ethyl
acetate 70:30) followed by HPLC purification (hexane/ethyl acetate
70:30) to afford the desired compounds 12a–15a and 12b–15bwith
an average yield of 30%.
4.11.1. Bis-(R)-MPA ester of 6-[(10R,20S)-dihydroxypentyl]-2H-
pyran-2-one (12a)
[a]D
25þ14.7 (c 0.17, MeOH). IR (film): nmax¼1747, 1643,1560, 1167,
1112, 805 cm1. 1H NMR (400 MHz, CDCl3): d¼7.30–7.42 (m, 10H,
ArH), 6.76 (dd, J¼6.5, 9.5 Hz, 1H, 4-H), 6.02 (d, J¼9.5 Hz, 1H, 3-H),
5.49 (d, J¼4.6 Hz, 1H, 10-H), 5.29 (dt, J¼4.6, 9.2 Hz, 1H, 20-H), 5.17 (d,
J¼6.5 Hz, 1H, 5-H), 4.75 (s, 1H, MPA-H), 4.66 (s, 1H, MPA-H), 3.38 (s,
3H, OMe), 3.35 (s, 3H, OMe), 1.28–1.49 (m, 2H, 30-H), 0.94–1.04 (m,
2H, 40-H), 0.69 (t, J¼7.3 Hz, 3H, 50-H) ppm. 13C NMR (100 MHz,
CDCl3): d¼169.7 (s, CO-MPA),169.0 (s, CO-MPA),160.4 (s, C-2), 158.2
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(s, C-6), 142.1 (d, C-4), 136.1, 135.4, 129.1, 128.7, 128.7, 128.5, 127.4,
127.1 (8d, Benzyl-MPA), 115.4 (d, C-3), 102.7 (d, C-5), 82.5, 81.9 (2d,
CH-MPA), 72.3 (d, C-10), 72.1 (d, C-20), 57.3 (s, OMe), 57.2 (s, OMe),
32.1 (t, C-30), 17.8 (t, C-40), 13.4 (q, C-50) ppm. MS:m/z¼494 (5), 404
(33), 292 (87), 268 (41), 218 (35), 230 (52), 130 (100), 95 (14), 71
(45). HRMS calcd. for C28H30O8: 494.1940; found: 494.1947 [M]
þ.
4.11.2. Bis-(R)-MPA ester of 6-[(10S,20R)-dihydroxypentyl]-2H-
pyran-2-one (13a)
[a]D
25 117.6 (c 0.28, MeOH). IR (film): nmax¼1751, 1639, 1560,
1165, 1112, 804 cm1. 1H NMR (400 MHz, CDCl3): d¼7.34–7.46 (m,
10H, ArH), 6.70 (dd, J¼6.7, 9.2 Hz, 1H, 4-H), 5.97 (d, J¼9.2 Hz, 1H,
3-H), 5.39 (d, J¼2.6 Hz, 1H, 10-H), 5.24 (ddd, J¼2.6, 4.6, 8.7 Hz,
1H, 20-H), 5.12 (d, J¼6.7 Hz, 1H, 5-H), 4.78 (s, 1H, MPA-H), 4.62
(s, 1H, MPA-H), 3.38 (s, 3H, OMe), 3.29 (s, 3H, OMe), 1.08–1.26
(m, 2H, 30-H), 1.10 (m, 2H, 40-H), 0.69 (t, J¼7.0 Hz, 3H, 50-H) ppm. 13C
NMR (100 MHz, CDCl3): d¼169.3 (s, CO-MPA), 169.1 (s, CO-MPA),
160.5 (s, C-2), 158.0 (s, C-6), 142.2 (d, C-4), 136.3, 135.5, 129.1, 128.7,
128.6, 128.4, 127.3, 127.1 (8d, Benzyl-MPA), 114.9 (d, C-3), 102.3
(d, C-5), 82.1, 81.9 (2d, CH-MPA), 72.1 (d, C-10), 71.6 (d, C-20), 57.3
(s, OMe), 57.2 (s, OMe), 32.0 (t, C-30), 18.2 (t, C-40), 13.4 (q, C-50) ppm.
HRMS calcd. for C28H30O8: 494.1940; found: 494.1988 [M]
þ.
4.11.3. Bis-(S)-MPA ester of 6-[(10R,20S)-dihydroxypentyl]-2H-
pyran-2-one (12b)
[a]D
25 þ120.5 (c 0.19, MeOH). IR (film): nmax¼1748, 1643, 1560,
1165, 1106, 803 cm1. 1H NMR (400 MHz, CDCl3): d¼7.34–7.46 (m,
10H, ArH), 6.70 (dd, J¼6.7, 9.2 Hz, 1H, 4-H), 5.97 (d, J¼9.2 Hz, 1H,
3-H), 5.40 (d, J¼2.6 Hz, 1H, 10-H), 5.24 (ddd, J¼2.6, 4.6, 8.7 Hz,
1H, 20-H), 5.12 (d, J¼6.7 Hz, 1H, 5-H), 4.78 (s, 1H, MPA-H), 4.62
(s, 1H, MPA-H), 3.38 (s, 3H, OMe), 3.29 (s, 3H, OMe), 1.08–1.26
(m, 2H, 30-H), 1.10 (m, 2H, 40-H), 0.69 (t, J¼7.0 Hz, 3H, 50-H) ppm. 13C
NMR (100 MHz, CDCl3): d¼169.3 (s, CO-MPA), 169.1 (s, CO-MPA),
160.5 (s, C-2), 158.0 (s, C-6), 142.2 (d, C-4), 136.3, 135.5, 129.1, 128.7,
128.6, 128.4, 127.3, 127.1 (8d, Benzyl-MPA), 114.9 (d, C-3), 102.3
(d, C-5), 82.1, 81.9 (2d, CH-MPA), 72.1 (d, C-10), 71.6 (d, C-20), 57.3
(s, OMe), 57.2 (s, OMe), 32.0 (t, C-30), 18.2 (t, C-40), 13.4 (q, C-50) ppm.
HRMS calcd. for C28H30O8: 494.1940; found: 494.1956 [M]
þ.
4.11.4. Bis-(S)-MPA ester of 6-[(10S,20R)-dihydroxypentyl]-2H-
pyran-2-one (13b)
[a]D
25 12.4 (c 0.24, MeOH). IR (film): nmax¼1747, 1642, 1560,
1167, 1113, 805 cm1. 1H NMR (400 MHz, CDCl3): d¼7.30–7.42 (m,
10H, ArH), 6.76 (dd, J¼6.5, 9.5 Hz, 1H, 4-H), 6.02 (d, J¼9.5 Hz, 1H,
3-H), 5.49 (d, J¼4.6 Hz, 1H, 10-H), 5.30 (dt, J¼4.6, 9.0 Hz, 1H, 20-H),
5.17 (d, J¼6.5 Hz, 1H, 5-H), 4.76 (s, 1H, MPA-H), 4.66 (s, 1H, MPA-H),
3.39 (s, 3H, OMe), 3.35 (s, 3H, OMe), 1.28–1.49 (m, 2H, 30-H), 0.94–
1.04 (m, 2H, 40-H), 0.69 (t, J¼7.3 Hz, 3H, 50-H) ppm. 13C NMR
(100 MHz, CDCl3) d¼169.7 (s, CO-MPA), 169.0 (s, CO-MPA), 160.4 (s,
C-2), 158.2 (s, C-6), 142.1 (d, C-4), 136.1, 135.4, 129.1, 128.7, 128.7,
128.5, 127.4, 127.1 (8d, Benzyl-MPA), 115.4 (d, C-5), 102.7 (d, C-3),
82.5, 81.9 (2d, CH-MPA), 72.3 (d, C-10), 72.1 (d, C-20), 57.3 (s, OMe),
57.2 (s, OMe), 32.1 (t, C-30), 17.8 (t, C-40), 13.4 (q, C-50) ppm. HRMS
calcd. for C28H30O8: 494.1940; found: 494.1946 [M]
þ.
4.11.5. Bis-(R)-MPA ester of 6-[(10S,20S)-dihydroxypentyl]-2H-
pyran-2-one (14a)
[a]D
25 97.9 (c 0.24, MeOH). IR (film): nmax¼1750, 1641, 1560,
1165, 1107, 805 cm1. 1H NMR (400 MHz, CDCl3): d¼7.26–7.44 (m,
10H, ArH), 7.10 (dd, J¼6.5, 9.3 Hz, 1H, 4-H), 6.16 (d, J¼9.3 Hz, 1H, 3-
H), 5.97 (d, J¼6.5 Hz,1H, 5-H), 5.52 (d, J¼6.4 Hz,1H,10-H), 5.15 (ddd,
J¼3.6, 6.4, 9.5 Hz,1H, 20-H), 4.79 (s,1H, MPA-H), 4.51 (s,1H, MPA-H),
3.37 (s, 3H, OMe), 3.33 (s, 3H, OMe),1.01–1.18 (m, 2H, 30-H), 0.73 (m,
2H, 40-H), 0.48 (t, J¼7.3 Hz, 3H, 50-H) ppm. 13C NMR (100 MHz,
CDCl3): d¼169.4 (s, CO-MPA),169.0 (s, CO-MPA),160.5 (s, C-2),158.0
(s, C-6), 142.4 (d, C-4), 135.8, 135.4, 128.9, 128.6, 128.5, 128.3, 127.1,
126.8 (8d, Benzyl-MPA), 115.7 (d, C-3), 104.3 (d, C-5), 82.1, 81.9 (2d,
CH-MPA), 72.2 (d, C-10), 71.7 (d, C-20), 57.3 (s, OMe), 57.2 (s, OMe),
30.8 (t, C-30), 17.2 (t, C-40), 13.1 (q, C-50) ppm. HRMS calcd. for
C28H30O8: 494.1940; found: 494.1950 [M]
þ.
4.11.6. Bis-(R)-MPA ester of 6-[(10R,20R)-dihydroxypentyl]-2H-
pyran-2-one (15a)
[a]D
25 þ14.8 (c 0.26, MeOH). IR (film): nmax¼1744, 1638, 1560,
1168, 1104, 805 cm1. 1H NMR (400 MHz, CDCl3): d¼7.25–7.36 (m,
10H, ArH), 6.76 (dd, J¼6.4, 9.2 Hz, 1H, 4-H), 6.00 (d, J¼9.2 Hz, 1H,
3-H), 5.41 (d, J¼4.6 Hz, 1H, 10-H), 5.36 (dt, J¼4.6, 6.4 Hz, 1H, 20-H),
5.04 (d, J¼6.4 Hz, 1H, 5-H), 4.67 (s, 1H, MPA-H), 4.62 (s, 1H, MPA-H),
3.37 (s, 3H, OMe), 3.33 (s, 3H, OMe),1.56 (m, J¼7.4, 6.4 Hz, 2H, 30-H),
1.22–1.33 (m, 2H, H-40), 0.86 (t, J¼7.3 Hz, 3H, 50-H) ppm. 13C NMR
(100 MHz, CDCl3): d¼169.6 (s, CO-MPA), 168.7 (s, CO-MPA), 160.4 (s,
C-2), 157.6 (s, C-6), 142.3 (d, C-4), 136.0, 135.3, 128.8, 128.7, 128.6,
127.3, 127.1 (8d, Benzyl-MPA),115.2 (d, C-3), 103.7 (d, C-5), 82.1, 81.8
(2d, CH-MPA), 72.4 (d, C-10), 72.1 (d, C-20), 57.4 (s, OMe), 57.2 (s,
OMe), 31.9 (t, C-30), 18.3 (t, C-40), 13.5 (q, C-50) ppm. HRMS calcd. for
C28H30O8: 494.1940; found: 494.1923 [M]
þ.
4.11.7. Bis-(S)-MPA ester of 6-[(10S,20S)-dihydroxypentyl]-2H-
pyran-2-one (14b)
[a]D
25 13.4 (c 0.26, MeOH). IR (film): nmax¼1744, 1638, 1560,
1169, 1105, 805 cm1. 1H NMR (400 MHz, CDCl3): d¼7.26–7.37 (m,
10H, ArH), 6.76 (dd, J¼6.7, 9.2 Hz, 1H, 4-H), 6.01 (d, J¼9.2 Hz, 1H,
3-H), 5.41 (d, J¼4.6 Hz, 1H, 10-H), 5.37 (dt, J¼4.6, 6.4 Hz, 1H, 20-H),
5.05 (d, J¼6.7 Hz, 1H, 5-H), 4.68 (s, 1H, MPA-H), 4.64 (s, 1H, MPA-H),
3.39 (s, 3H, OMe), 3.35 (s, 3H, OMe),1.58 (m, J¼7.4, 6.4 Hz, 2H, 30-H),
1.22–1.33 (m, 2H, 40-H), 0.87 (t, J¼7.3 Hz, 3H, 50-H) ppm. 13C NMR
(100 MHz, CDCl3): d¼169.4 (s, CO-MPA), 168.6 (s, CO-MPA), 160.2 (s,
C-2), 157.4 (s, C-6), 142.2 (d, C-4), 135.9, 135.1, 128.7, 128.6, 128.4,
127.2, 127.0 (8d, Benzyl-MPA), 115.0 (d, C-3), 103.6 (d, C-5), 82.0,
81.7 (2d, CH-MPA), 72.2 (d, C-10), 72.0 (d, C-20), 57.2 (s, OMe), 57.0 (s,
OMe), 31.7 (t, C-30), 18.1 (t, C-40), 13.3 (q, C-50) ppm. HRMS calcd. for
C28H30O8: 494.1940; found: 494.1953 [M]
þ.
4.11.8. Bis-(S)-MPA ester of 6-[(10R,20R)-dihydroxypentyl]-2H-
pyran-2-one (15b)
[a]D
25 þ96.1 (c 0.22, MeOH). IR (film): nmax¼1748, 1644, 1562,
1166, 1113, 806 cm1. 1H NMR (400 MHz, CDCl3): d¼7.28–7.44 (m,
10H, ArH), 7.10 (dd, J¼6.5, 9.3 Hz, 1H, H-4), 6.17 (d, J¼9.3 Hz, 1H,
H-3), 5.98 (d, J¼6.5 Hz, 1H, H-5), 5.52 (d, J¼6.4 Hz, 1H, H-10), 5.15
(ddd, J¼3.6, 6.4, 9.5 Hz, 1H, H-20), 4.80 (s, 1H, H-MPA), 4.53 (s, 1H,
H-MPA), 3.38 (s, 3H, OMe), 3.34 (s, 3H, OMe), 1.02–1.17 (m, 2H,
H-30), 0.74 (m, 2H, H-40), 0.49 (t, J¼7.3 Hz, 3H, H-50) ppm. 13C NMR
(100 MHz, CDCl3): d¼169.4 (s, CO-MPA), 169.0 (s, CO-MPA), 160.5 (s,
C-2), 158.0 (s, C-6), 142.4 (d, C-4), 135.8, 135.4, 128.9, 128.6, 128.5,
128.3, 127.1, 126.8 (8d, Benzyl-MPA), 115.7 (d, C-3), 104.3 (d, C-5),
82.1, 81.9 (2d, CH-MPA), 72.2 (d, C-10), 71.7 (d, C-20), 57.3 (s, OMe),
57.2 (s, OMe), 30.8 (t, C-30), 17.2 (t, C-40), 13.1 (q, C-50) ppm. HRMS
calcd. for C28H30O8: 494.1940; found: 494.1950 [M]
þ.
4.12. Hydrolysis of Mosher’s esters: general procedure
The corresponding Mosher’s ester (10 mg, 0.02 mmol) was
dissolved in methanol (5 mL). Then three drops of an aqueous
solution of K2CO3 (6.1 mg, 0.044 mmol) were added and the mix-
ture was stirred at room temperature for 3 min. The reaction
mixture was directly chromatographed on flash chromatography
column (silica gel, hexane/ethyl acetate 2:3) to yield the desired
product 6-[(10R,20S)-dihydroxypentyl]-2H-pyran-2-one (12) (76%),
[a]D
25 þ120.6 (c 0.15, MeOH); 6-[(10S,20R)-dihydroxypentyl]-2H-py-
ran-2-one (13) (75%), [a]D
25 123.1 (c 0.1, MeOH); 6-[(10S,20S)-
dihydroxypentyl]-2H-pyran-2-one (14) (80%), [a]D
25 79.6 (c 0.5,
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MeOH); or 6-[(10R,20R)-dihydroxypentyl]-2H-pyran-2-one (15)
(78%), [a]D
25 þ81.3 (c 0.13, MeOH).
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